The study of therapeutic effect on malignant obstructive jaundice by biliary stent combined with 125I particle strip implantation

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000030878

Enrollment

Unknown

Registered

2020-03-16

Start date

2016-01-01

Completion date

Unknown

Last updated

2020-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

malignant obstructive jaundice

Interventions

combind group:combind 125I

control group:stent only

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. aged 18-80 years; 2. ECOG score <=2; 3. pathological or clinical diagnosis of obstructive jaundice caused by malignant tumor, unable or unwilling to perform surgery; 4. no serious cardiovascular and cerebrovascular disease; 5. no serious abnormal coagulation function; 6. willing to accept this study and sign informed consent.

Exclusion criteria

Exclusion criteria: 1. suspected benign biliary stricture; 2. presence of severe cardiovascular and cerebrovascular disease; 3. presence of severe coagulation dysfunction; 4. patients with reobstruction after biliary stenting or drainage.

Design outcomes

Primary

Measure	Time frame
Survival time;Stent opening time;	—

Countries

China

Contacts

Public ContactHe Dongfeng

Harbin Medical University Cancer Hospital

13644578588@139.com+86 13644578588

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026